Prevention of Oxygen-Induced Inflammatory Lung Injury by Caffeine in Neonatal Rats.
Stefanie EndesfelderEvelyn StraußIvo BendixThomas SchmitzChristoph BührerPublished in: Oxidative medicine and cellular longevity (2020)
The present study investigating the impact of caffeine on the inflammatory response, pulmonary cell degeneration and modulation of adenosine receptor expression, provides further evidence that caffeine acts as an antioxidative and anti-inflammatory drug for experimental oxygen-mediated lung injury. Experimental studies may broaden the understanding of therapeutic use of caffeine in modulating detrimental mechanisms involved in BPD development.